Browse
Browse and Search
Search
Explore more content
12933_2021_1228_MOESM2_ESM.
docx
(17.64 kB)
File info
This item contains files with download restrictions
Fullscreen
Additional file 2 of A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study
Cite
Download
(17.64 kB)
Share
Embed
journal contribution
posted on 2021-02-03, 04:31
authored by
Shigenori Hiruma
,
Fumika Shigiyama
,
Shinji Hisatake
,
Sunao Mizumura
,
Nobuyuki Shiraga
,
Masaaki Hori
,
Takanori Ikeda
,
Takahisa Hirose
,
Naoki Kumashiro
Additional file 2. Adverse events (list of observed adverse events).
Funding
Boehringer Ingelheim Eli Lilly Japan
History
Usage metrics
Categories
Biochemistry
Medicine
Physiology
Pharmacology
Biotechnology
Chemical Sciences not elsewhere classified
Developmental Biology
Virology
Keywords
DPP-4 inhibitor
Early-stage type 2 diabetes mellitus
Epicardial fat
123I-BMIPP scintigraphy
Myocardial triglyceride content
Pericardial fat
Preserved cardiac function
SGLT2 inhibitor
Licence
CC BY + CC0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC